Cellectis (CLLS) Other Operating Expenses (2015 - 2026)
Cellectis (CLLS) posted quarterly Other Operating Expenses of $63000.0 for Q1 2026, down 85.21% year-over-year from $426000.0 in Q1 2025, and up 119.69% quarter-over-quarter from -$320000.0 in Q4 2025.
Cellectis (CLLS) Other Operating Expenses (2015 - 2026) Analysis & Trends
Cellectis' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $63000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 85.21% year-over-year to $63000.0; the TTM figure through Mar 2026 stood at $275000.0 (down 77.82% YoY), while the FY2025 annual figure was $849000.0, changed 0.0% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $63000.0, up from -$320000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $839000.0 in Q4 2022, with the low at -$1.2 million in Q4 2023.
- The 5-year median for Other Operating Expenses is $63000.0 (2026), against an average of $102294.1.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses soared 11885.71% in 2022, then sank 3009.52% in 2023.
- Cellectis' Other Operating Expenses stood at $839000.0 in 2022, then tumbled by 243.5% to -$1.2 million in 2023, then jumped by 96.1% to -$47000.0 in 2024, then slumped by 580.85% to -$320000.0 in 2025, then surged by 119.69% to $63000.0 in 2026.
- Business Quant data shows CLLS's Other Operating Expenses at $63000.0 in Q1 2026, -$320000.0 in Q4 2025, and $154000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | -320,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | -12,000.00 |
| Jun 30, 2023 | 528,000.00 |
| Mar 31, 2023 | -611,000.00 |
| Dec 31, 2022 | 839,000.00 |
| Sep 30, 2022 | -125,000.00 |
| Jun 30, 2022 | 753,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 150,000.00 |